30 patents currently held
7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Mar 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
13
Ending by 2030
Mar 2027
Next term end
16
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2029 · High confidence
Also notable
Ends no later than Apr 2030 · Medium confidence
Also notable
Ends Jul 2037 · High confidence
Live Attenuated Bordetella Strains as a Single Dose Vaccine Against Whooping cough
US 9,119,804
The largest patent family in this portfolio, 9 related applications, renewed at every maintenance window due so far. Protection runs to 2029.
Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology
US 11,110,161
A family of 8 related applications built on the 2021 grant. Protection runs to 2030. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Mutant Bordetella Strains and Methods of Use
US 10,682,377
Granted 2020. Computed term ends 2037.
Formerly held, still cited
Notable
Ends Jun 2029 · High confidence
The largest patent family in this portfolio, 5 related applications, renewed at every maintenance window due so far. Protection runs to 2029.
now held by National University of Singapore
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 6, 2027The maintenance fee for Prevention of Pertussis Using Adenylate Cyclase Deficient Bordetella Strains (US 10,369,207) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
- 2 fees due Mar 1 to 24, 2027 · next Mar 1
- 1 fee due May 21, 2027The maintenance fee for Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology (US 11,819,545) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
- 1 fee due Sep 12, 2027The maintenance fee for Methods and Pharmaceutical Compositions for Modulating Monocytopoiesis (US 11,926,664) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
- 1 fee due Nov 7, 2027The maintenance fee for Pyropheophorbide Conjugate and Use Thereof in the Treatment of Cancer and as a Fluorescent Marker (US 11,975,072) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 16 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology | 6 in force | to Apr 2030 |
| Live Attenuated Bordetella Strains as a Single Dose Vaccine Against Whooping cough | 6 in force | to Nov 2029 |
| Adenylate Cyclase Deficient Bordetella Strains | 3 in force | to Sep 2035 |
| Bordetella Strains Expressing Serotype 3 Fimbriae | 2 in force | to Mar 2040 |
| Mutant Bordetella Strains and Methods of Use | 2 in force | to Jul 2037 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,180,178 | Method of Using Attenuated Bordetella Strains In force · High confidence | In force | High confidence | |
| US 10,258,681 | Attenuated Bordetella Strains In force · High confidence | In force | High confidence | |
| US 10,610,580 | Attenuated Bordetella Strains In force · High confidence | In force | High confidence | |
| US 11,285,201 | Attenuated Bordetella Strains In force · High confidence | In force | High confidence | |
| US 9,730,995 | Attenuated Bordetella Strains In force · High confidence | In force | High confidence | |
| US 9,119,804 | Live Attenuated Bordetella Strains as a Single Dose Vaccine Against Whooping cough held by Institut Pasteur de Lille and Institut National de la Sante et de la Recherche Medicale (Inserm) In force · High confidence | In force | High confidence | |
| US 8,986,709 | Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology held by Inserm (Institut National de la Sante et de la Recherche Medicale), Institut Pasteur de Lille and National University of Ireland Maynooth In force · High confidence | In force | High confidence | |
| US 9,839,683 | Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology held by Inserm (Institut National de la Sante et de la Recherche Medicale, Institut Pasteur de Lille and National University of Ireland Maynooth In force · High confidence | In force | High confidence | |
| US 10,420,827 | Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology In force · High confidence | In force | High confidence | |
| US 10,653,765 | Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology In force · High confidence | In force | High confidence |
Also on record, not counted in the 30: 7 patents in force now held by others · 19 patents ended · 21 applications pending · 40 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.